Charles River Labs Intl sell CLSA
Start price
18.11.24
/
50%
€177.05
Target price
18.11.25
€155.14
Performance (%)
-21.21%
End price
19.11.25
€139.50
Summary
This prediction ended on 19.11.25 with a price of €139.50. The prediction for Charles River Labs Intl closed with a convincing performance of -21.21%. CLSA has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 1.549% | 1.549% | 25.378% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by CLSA for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von CLSA gewählte maximale Laufzeit wurde überschritten